Riskpilot← Back to searchSign inGet full accessKLINIKK HAUSKEN AS
ASActiveOrg 997384830Karmsundgata 59, 5531 HaugesundMedical specialists activities · NACE 8622Est. 201141 employeeswww.klinikkhausken.no
Revenue 2024
NOK 94,1M
-3% vs 2023
EBITDA margin
-6.4%
-61% vs 2023
Equity ratio
-40.5%
Financial strength
Net profit 2024
NOK -7,8M
-27% vs 2023
| Revenue | NOK 94,1M | -3% |
| EBITDA | NOK -6,1M | -61% |
| Net profit | NOK -7,8M | -27% |
| Total assets | NOK 23,5M | +2% |
| Equity | NOK -9,5M | -454% |
| Employees | 41 | — |
Legal name
KLINIKK HAUSKEN AS
Org number
997384830
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
23. september 2011
Share capital
NOK 200 000
Employees
41 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
John paul stubbington james roderick barr piotr wojciechowski arne schwennicke jon wegner hausken
Company purpose
Medisinsk infertilitetsbehandling og alt som står i forbindelse med dette, inkludert å investere i andre selskaper som opererer innenfor samme forretningsområde.
Address
Karmsundgata 59, 5531 Haugesund
Phone
+4752738855
Website
www.klinikkhausken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 68 381 | 78 667 | 78 525 | 97 094 | 94 133 |
| Staff expenses | −27 821 | −29 842 | −36 669 | −46 215 | −43 991 |
| EBITDA | 10 475 | 17 421 | 723 | −3 758 | −6 055 |
| Depreciation & amort. | −2 094 | −2 201 | −2 764 | −3 487 | −2 945 |
| EBIT | 8 381 | 15 220 | −2 041 | −7 246 | −9 000 |
| Net financials | −302 | 10 | −175 | −664 | −1 011 |
| Profit before tax | 8 079 | 15 230 | −2 216 | −7 910 | −10 011 |
| Tax | 1 778 | 3 351 | −487 | −1 740 | −2 202 |
| Net profit | 6 301 | 11 880 | −1 730 | −6 170 | −7 809 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 24 137 | 27 092 | 25 929 | 23 006 | 23 534 |
| Equity | 200 | 6 180 | 4 450 | −1 720 | −9 528 |
| Long-term debt | 4 353 | 0 | 8 000 | 10 000 | 10 000 |
| Short-term debt | 19 584 | 20 912 | 13 478 | 14 726 | 23 063 |
| Total debt | 23 937 | 20 912 | 21 478 | 24 726 | 33 063 |
EBITDA margin
-6.4%
This company
15.8%
Market median
-141% vs market
20202024
Equity ratio
-40.5%
This company
38.2%
Market median
-206% vs market
20202024
Return on equity
-780862400.0%
This company
18.4%
Market median
-4243817491% vs market
20202024
Net profit margin
-8.3%
This company
8.1%
Market median
-202% vs market
20202024
Asset turnover
4.00×
This company
1.12×
Market median
+257% vs market
20202024
Debt / equity
3.47×
This company
0.62×
Market median
-460% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JW Chief Executive Officer | Chief Executive Officer | 2011 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Board of Directors | 2024 | |
| Former (7) | ||
| Board of Directors | 2021 – 2023 | |
| Board of Directors | 2019 – 2021 | |
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2019 – 2021 | |
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2021 – 2023 | |
| Board of Directors | 2019 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 70% | 70% | 2024 | |
| Company | 21% | 21% | 2024 | |
| Company | 9% | 9% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Medicover Norway As
KLINIKK HAUSKEN AS Board members of KLINIKK HAUSKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jon Wegner Hausken | Chief Executive Officer | 0 companies |
| James Roderick Barr | Board of Directors | 0 companies |
| Elise Odland Amundsen | Board of Directors | 0 companies |
| Anders Palm | Board of Directors | 0 companies |
| John Paul Stubbington | Chairman | 0 companies |
| Ove Nedrebø | Board of Directors | 0 companies |
| Marcin Jakub Lukasiewicz | Board of Directors | 0 companies |
| Piotr Wojciechowski | Board of Directors | 0 companies |
| Arne Schwennicke | Board of Directors | 0 companies |
| Piotr Tomasz Lach | Board of Directors | 0 companies |
| Kristian Bendik Hausken | Board of Directors | 0 companies |